Trials / Completed
CompletedNCT05703867
Transpalpebral Microcurrent Stimulation for the Improvement of Visual Acuity in Patients With Macular Degeneration
Interventional Study of Transpalpebral Microcurrent Stimulation for the Improvement of Visual Acuity in Patients With Macular Degeneration
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 404 (actual)
- Sponsor
- Jarding, John, OD · Individual
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to evaluate the effectiveness of transpalpebral microcurrent stimulation as a therapy for dry age-related macular degeneration. Participants are assessed at baseline for visual acuity and treated for 4 consecutive days for a total of 8 sessions (2 per day) with microcurrent stimulation. A follow-up visit is conducted to evaluate the participant and collect follow-up visual acuity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Active microcurrent therapy | Non-invasive transpalpebral microcurrent therapy delivery to the upper and lower eyelids |
Timeline
- Start date
- 1998-01-01
- Primary completion
- 1999-12-01
- Completion
- 1999-12-01
- First posted
- 2023-01-30
- Last updated
- 2023-01-31
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05703867. Inclusion in this directory is not an endorsement.